[ Transactional ] as a Relevant Course outside SLS for those interested in Lifesciences: Innovations : Students interested in lifesciences should consider taking one or more courses on the market and regulatory issues raised by innovation in the health care industry. These issues are often at the heart of litigation in the lifesciences industry.
This course considers regulatory approval and reimbursement for new medical technologies as a key component of product commercialization, with a focus on regenerative medicine therapies.

General course
Description:

The science of stem cells and regenerative medical therapies has progressed dramatically in the last decade. Some medical scientists are arguing that within our lifetimes many serious medical conditions (e.g., heart disease, diabetes, Parkinsons) may be halted or reversed by these therapies. Needless to say, these technologies could radically change the landscape and economics of the pharmaceutical and healthcare industries. While the promise of regenerative therapies is great, significant ethical, scientific, and financial hurdles remain. To date, little attention has been paid to the role that businesses will play in moving research from the medical lab to the marketplace. This seminar will explore the role that business can and will play in the development and commercialization of regenerative medicine therapies. In particular, we will consider the challenges that venture capitalists and managers face in funding new ideas and bringing these ideas to market. This seminar will: -

Course Style: A Substantive course teaches the law, theory, and policy in a particular area of law